Thema
Journal Article
1.634
PARP inhibitors
1.250
PARP inhibitor
1.199
Poly(ADP-ribose) Polymerase Inhibitors
851
Review
711
Research Support, Non-U.S. Gov't
471
Antineoplastic Agents
362
olaparib
353
Ovarian cancer
305
ovarian cancer
290
EC 2.4.2.30
281
Phthalazines
262
BRCA1 Protein
249
BRCA
228
WOH1JD9AR8
214
Poly(ADP-ribose) Polymerases
209
Piperazines
204
BRCA2 Protein
199
Olaparib
187
BRCA1 protein, human
178
DNA repair
169
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
157
BRCA2 protein, human
141
Research Support, N.I.H., Extramural
135
BRCA1
127
breast cancer
121
Breast cancer
119
BRCA2
117
niraparib
112
Poly (ADP-Ribose) Polymerase-1
107
immunotherapy
105
rucaparib
102
prostate cancer
98
homologous recombination
97
talazoparib
95
PARP Inhibitor
90
BRCA mutation
86
DNA damage repair
86
DNA damage
85
synthetic lethality
85
Biology (General)
78
Immunotherapy
78
Niraparib
78
Case Reports
77
veliparib
76
PARP1 protein, human
75
Synthetic lethality
75
DNA damage response
72
Bevacizumab
65
Biomarkers, Tumor
65
mehr ...